Suzan Tabur

536 total citations
36 papers, 424 citations indexed

About

Suzan Tabur is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Suzan Tabur has authored 36 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Suzan Tabur's work include Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (5 papers) and Neuropeptides and Animal Physiology (4 papers). Suzan Tabur is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (5 papers) and Neuropeptides and Animal Physiology (4 papers). Suzan Tabur collaborates with scholars based in Türkiye. Suzan Tabur's co-authors include Nurten Aksoy, Mesut Özkaya, Tevfik Sabuncu, Hakan Korkmaz, Eli̇f Oğuz, Mehmet Ali Eren, Ersin Akarsu, Esen Savaş, Serdar Öztuzcu and Zeynel Abidin Sayıner and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Endocrinology and International Journal of Gynecology & Obstetrics.

In The Last Decade

Suzan Tabur

36 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzan Tabur Türkiye 12 140 96 60 53 52 36 424
Regina Wikinski Argentina 11 147 1.1× 55 0.6× 78 1.3× 82 1.5× 86 1.7× 24 504
Cahide Gökkuşu Türkiye 12 68 0.5× 82 0.9× 33 0.6× 50 0.9× 71 1.4× 28 427
Serap Cilaker Türkiye 12 74 0.5× 91 0.9× 22 0.4× 45 0.8× 37 0.7× 20 491
Amelia K. Fotheringham Australia 11 243 1.7× 157 1.6× 183 3.0× 84 1.6× 103 2.0× 20 567
Zimiao Chen China 12 189 1.4× 156 1.6× 13 0.2× 57 1.1× 83 1.6× 27 568
Médea Veszelka Hungary 10 75 0.5× 130 1.4× 13 0.2× 109 2.1× 81 1.6× 20 427
Moshira Rateb Egypt 6 68 0.5× 96 1.0× 49 0.8× 78 1.5× 43 0.8× 9 355
Murat Olukman Türkiye 12 54 0.4× 81 0.8× 29 0.5× 98 1.8× 64 1.2× 27 448
Marie-José Drittij-Reijnders Netherlands 11 123 0.9× 82 0.9× 19 0.3× 35 0.7× 20 0.4× 14 579
Morihiko Maeda Japan 9 79 0.6× 128 1.3× 30 0.5× 205 3.9× 61 1.2× 10 532

Countries citing papers authored by Suzan Tabur

Since Specialization
Citations

This map shows the geographic impact of Suzan Tabur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzan Tabur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzan Tabur more than expected).

Fields of papers citing papers by Suzan Tabur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzan Tabur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzan Tabur. The network helps show where Suzan Tabur may publish in the future.

Co-authorship network of co-authors of Suzan Tabur

This figure shows the co-authorship network connecting the top 25 collaborators of Suzan Tabur. A scholar is included among the top collaborators of Suzan Tabur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzan Tabur. Suzan Tabur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydın, Neriman, Seval Kul, Gülendam Karadağ, Suzan Tabur, & Mustafa Araz. (2019). Effect of Ramadan fasting on glycaemic parameters & body mass index in type II diabetic patients. The Indian Journal of Medical Research. 150(6). 546–556. 12 indexed citations
2.
Tabur, Suzan, Hakan Korkmaz, Mehmet Ali Eren, et al.. (2016). Can Visfatin be Considered as a Diagnostic Marker for Diabetic Nephropathy?. SHILAP Revista de lepidopterología. 20(1). 10–15. 1 indexed citations
3.
Tabur, Suzan, Serdar Öztuzcu, Eli̇f Oğuz, et al.. (2016). Evidence for elevated (LIMK2 and CFL1) and suppressed (ICAM1, EZR, MAP2K2, and NOS3) gene expressions in metabolic syndrome. Endocrine. 53(2). 465–470. 9 indexed citations
4.
Korkmaz, Hakan, Suzan Tabur, Esen Savaş, et al.. (2016). Evaluation of Serum S100A8/S100A9 Levels in Patients with Autoimmune Thyroid Diseases. Balkan Medical Journal. 33(5). 547–551. 10 indexed citations
5.
Tabur, Suzan, et al.. (2016). Auditory changes in acromegaly. Journal of Endocrinological Investigation. 40(6). 621–626. 1 indexed citations
6.
Tabur, Suzan, et al.. (2015). Role of the transient receptor potential (TRP) channel gene expressions and TRP melastatin (TRPM) channel gene polymorphisms in obesity-related metabolic syndrome.. PubMed. 19(8). 1388–97. 26 indexed citations
7.
Oğuz, Eli̇f, et al.. (2015). ICAM-1 E469K and E-Selectin S128R Polymorphisms with Non-Diabetic Metabolic Syndrome. DergiPark (Istanbul University). 12(1). 58–66. 1 indexed citations
8.
Oğuz, Eli̇f, et al.. (2015). Effects of Lycopene Alone or Combined with Melatonin on Methotrexate-Induced Nephrotoxicity in Rats. Asian Pacific Journal of Cancer Prevention. 16(14). 6061–6066. 22 indexed citations
9.
Tabur, Suzan, et al.. (2015). Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy?. Diabetology & Metabolic Syndrome. 7(1). 36–36. 11 indexed citations
10.
Korkmaz, Hakan, Suzan Tabur, Mesut Özkaya, et al.. (2015). Serum prolidase levels in Graves’ disease without ophthalmopathy and its association with oxidative status. Journal of Endocrinological Investigation. 38(11). 1167–1173. 8 indexed citations
11.
Tabur, Suzan, Hakan Korkmaz, Mesut Özkaya, et al.. (2015). Serum calprotectin: a new potential biomarker for thyroid papillary carcinoma. Tumor Biology. 36(10). 7549–7556. 8 indexed citations
12.
Tabur, Suzan, et al.. (2015). The effects of lycopene on intestinal injury due to methotrexate in rats. Redox Report. 21(3). 113–118. 25 indexed citations
13.
Sabuncu, Tevfik, et al.. (2014). High Serum Concentration of Interleukin-18 in Diabetic Patients with Foot Ulcers. Journal of the American Podiatric Medical Association. 104(3). 222–226. 7 indexed citations
14.
Tabur, Suzan, Eli̇f Oğuz, Mehmet Ali Eren, et al.. (2014). Serum prolidase activity is associated with non-diabetic metabolic syndrome. Diabetology & Metabolic Syndrome. 6(1). 142–142. 8 indexed citations
15.
Tabur, Suzan, Hakan Korkmaz, Mehmet Ali Eren, et al.. (2014). Urotensin-II level and its association with oxidative stress in early diabetic nephropathy. Journal of Diabetes and its Complications. 29(1). 115–119. 21 indexed citations
16.
Tabur, Suzan, et al.. (2014). Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma. Tumor Biology. 36(4). 2667–2674. 35 indexed citations
17.
Tabur, Suzan, et al.. (2014). The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration. Wiener klinische Wochenschrift. 127(1-2). 45–50. 49 indexed citations
18.
Eren, Mehmet Ali, et al.. (2013). The relationship between microvascular complications and depression in patients with type 2 diabetes mellitus who use insulin. Journal of Clinical and Experimental Investigations. 4(1). 2 indexed citations
19.
Eren, Mehmet Ali, Ayşe Nur Torun, Suzan Tabur, et al.. (2012). Serum prolidase activity in diabetic foot ulcers. Acta Diabetologica. 50(3). 423–427. 10 indexed citations
20.
Tabur, Suzan, Tevfik Sabuncu, Mehmet Nuri Turan, et al.. (2009). Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation. European Journal of Endocrinology. 162(3). 535–541. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Regina Wikinski Breakdown of academic impact, for papers by Cahide Gökkuşu Breakdown of academic impact, for papers by Serap Cilaker Breakdown of academic impact, for papers by Amelia K. Fotheringham Breakdown of academic impact, for papers by Zimiao Chen Breakdown of academic impact, for papers by Médea Veszelka Breakdown of academic impact, for papers by Moshira Rateb Breakdown of academic impact, for papers by Murat Olukman Breakdown of academic impact, for papers by Marie-José Drittij-Reijnders Breakdown of academic impact, for papers by Morihiko Maeda
Rankless by CCL
2026